{"id":251763,"date":"2026-09-17T11:35:19","date_gmt":"2026-09-17T06:05:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=251763"},"modified":"2026-09-17T11:35:20","modified_gmt":"2026-09-17T06:05:20","slug":"par-drugs-and-chemicals-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/par-drugs-and-chemicals-bull-case-vs-bear-case-2026\/","title":{"rendered":"Par Drugs And Chemicals Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n
\n

Par Drugs And Chemicals Key Stats (17 Sep 2026)<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Sector<\/td>\nPharmaceutical Bulk Drugs and Intermediates Manufacturing<\/td>\n<\/tr>\n
Current Market Price<\/td>\nRs 130.89<\/td>\n<\/tr>\n
52 Week High \/ Low<\/td>\nRs 180.00 \/ Rs 78.05<\/td>\n<\/tr>\n
Market Cap (Rs Cr)<\/td>\n157<\/td>\n<\/tr>\n
P\/E Ratio (Industry P\/E)<\/td>\n10.80 (50.28)<\/td>\n<\/tr>\n
Return on Equity<\/td>\n11.71%<\/td>\n<\/tr>\n
Debt to Equity<\/td>\n0.00<\/td>\n<\/tr>\n
EPS (TTM)<\/td>\nRs 11.78<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.00%<\/td>\n<\/tr>\n
Book Value<\/td>\nRs 91.01<\/td>\n<\/tr>\n
14 Day RSI<\/td>\n62.67<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Quick Answer<\/strong><\/p>\n

The Par Drugs And Chemicals bull case rests on sharp single session rally, while the bear case points to neutral to positive technical setup. At Rs 130.89, the stock sits between its 52 week low of Rs 78.05 and high of Rs 180.00, and both sides of the argument deserve a look before deciding. This article lays out the fundamentals and technical signals so you can weigh the Par Drugs And Chemicals bull case against the risks yourself.<\/p>\n<\/div>\n

Par Drugs And Chemicals<\/a> operates in the pharmaceutical bulk drugs and intermediates manufacturing space, and its shares currently trade at Rs 130.89, placing the stock within a 52 week range of Rs 78.05 to Rs 180.00. For anyone building or reviewing a position, the Par Drugs And Chemicals bull case and the bear case both come down to the same underlying numbers read in different lights, and this piece walks through both sides using the company’s latest valuation, profitability, and technical readings.<\/p>\n

Rather than pushing you toward one conclusion, this Par Drugs And Chemicals bull case analysis sets out what the bulls see in Par Drugs And Chemicals shares and what the bears are watching, so you can match the picture against your own risk appetite and investment horizon. Understanding the Par Drugs And Chemicals bull case thoroughly, alongside its counterpart, is essential before making any investment decision.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n